Related Experiment Video
Updated: Feb 15, 2026

Enema of Traditional Chinese Medicine for Patients with Severe Acute Pancreatitis
Published on: January 27, 2023
Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese
Zhong Ling Zhuo, Hai Peng Xian, Yan Long
1Department of Clinical Laboratory, Peking University People's Hospital; Beijing-China. zhaoxt@bjmu.edu.cn.
Insights
Genetic variations in CYP2C19, specifically the *2 or *3 alleles, are linked to clopidogrel resistance in cardiovascular patients. ABCB1 gene variations did not show a significant association with clopidogrel resistance in this study.
Area of Science:
- Pharmacogenomics
- Cardiovascular Medicine
- Clinical Genetics
Background:
- Clopidogrel is a widely used antiplatelet medication for cardiovascular disease.
- Genetic polymorphisms can influence clopidogrel's efficacy, leading to variable patient responses.
- Understanding these genetic associations is crucial for personalized antiplatelet therapy.
Purpose of the Study:
- To investigate the association between specific genetic polymorphisms in CYP2C19 and ABCB1 genes and clopidogrel resistance (CR).
- To evaluate the impact of these genetic variations on antiplatelet response in patients with cardiovascular disease in Beijing.
Main Methods:
- A study involving 325 patients with cardiovascular disease, divided into experimental (n=101) and control (n=224) groups.
- Clopidogrel resistance was determined by adenosine diphosphate (ADP)-induced platelet inhibition rate using thromboelastography (TEG).
- Genotyping for CYP2C19 (*2, *3, *4, *5, *17) and ABCB1 polymorphisms was performed using time-of-flight mass spectrometry and Sanger sequencing.
Main Results:
- Carriage of CYP2C19*2 or *3 mutant alleles was significantly associated with lower ADP-induced platelet inhibition rates and increased risk of clopidogrel resistance (p<0.05).
- No significant correlation was found between ABCB1 genotypes and an increased risk of clopidogrel resistance.
- CYP2C19 heterozygous and homozygous genotypes (*1/*2, *1/*3, *2/*2, *2/*3) showed significantly reduced platelet inhibition compared to non-carriers.
Conclusions:
- The presence of CYP2C19*2 or *3 mutant alleles is a significant predictor of attenuated platelet response to clopidogrel and elevated clopidogrel resistance risk.
- CYP2C19 genetic variations play a critical role in clopidogrel efficacy in cardiovascular patients.
- ABCB1 gene polymorphisms were not found to be significantly associated with clopidogrel resistance in this patient cohort.
Objective:
To investigate the association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance (CR) in patients with cardiovascular disease in Beijing district.
Methods:
In total, 325 patients were enrolled in the study, including 101 experimental group patients and 224 control group patients. The experimental group was divided into CR group (n=30) and non-CR group (n=71) according to the adenosine diphosphate (ADP)-induced platelet inhibition rate in thromboelastography (TEG) (ADP-induced platelet inhibition rate of <30% was defined as CR and rate of 30%-100% was defined as non-CR). Genotypes, including CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*17, and ABCB1, were determined using time-of-flight mass spectrometry (Clin-TOF) and Sanger sequencing in all patients.
Results:
In the experimental group, carriers of CYP2C19 heterozygous (*1/*2, n=46; *1/*3, n=7), and mutation homozygous (*2/*2, n=7; *2/*3, n=3; *3/*3, n=0) genotypes showed significantly lower ADP-induced platelet inhibition rates than noncarriers (*1/*1, n=38; p=0.035 and 0.001, respectively); the carriage of mutant CYP2C19*2 or *3 allele was significantly associated with an increased risk of CR. In contrast, carriers of ABCB1 heterozygous (TC, n=50) showed significantly lower ADP-induced platelet inhibition rates than noncarriers (CC, n=39, p=0.097), and there was no significant correlation between ABCB1 genotypes and higher CR risk.
Conclusion:
The carriage of CYP2C19*2 or *3 mutant allele was significantly associated with attenuated platelet response to clopidogrel and increased CR risk. The carriage of ABCB1 mutant allele was not significantly associated with CR risk.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Associative Learning
Classical conditioning, also known...
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Resistivity
Resistance
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...

